The Regensburg-based digital health startup brainjo has closed a €2 million seed funding round, led by High-Tech Gründerfonds (HTGF), with additional participation from strategic partners and business angels, including Andreas Weinhut (Regensburg) and better ventures. Limited therapy availability, long waiting lists, and insufficient access to mental health services continue to challenge healthcare systems. brainjo aims to address these gaps by leveraging Virtual Reality (VR) as a prescribable extension to psychotherapy, designed to enhance patient adherence and accessibility. The company develops Digital Health Applications (DiGA) that can be prescribed by therapists or physicians and reimbursed by health insurance.

Rather than replacing traditional psychotherapy, these immersive VR-based solutions complement existing treatments by offering individualised and accessible therapy that patients can use from home. This approach helps bridge critical gaps in care where conventional therapy alone may fall short. Markus Wensauer, co-founder and CEO of brainjo, commented: With a strong network of business angels, MEDICE – The Health Family as a strategic partner, and HTGF as a leading European seed investor, we are ideally positioned to bring our solutions into healthcare and establish multimodal therapy offerings for patients.

The company’s mission is to create evidence-based, immersive therapy solutions that complement and scale existing treatment approaches. The newly secured capital will finance the next major milestone: a clinical study and the regulatory approval of brainjo’s first VR-based DiGA. This initial application, focused on children with ADHD, is being developed in collaboration with MEDICE – The Health Family. Market approval is currently planned for 2028.